SCHEMBL13047435

SCHEMBL13047435

CC(C)(C)Cn1ccc2c(NC(=O)c3cc(Cl)ccc3Cl)cccc2c1=O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.48
HPGD P15428 3/20 0.48
SMN1; SMN2 Q16637 3/20 0.48
KDM4E B2RXH2 2/20 0.48
NPSR1 Q6W5P4 2/20 0.48
CYP1A2 P05177 1/20 0.48
CYP3A4 P08684 1/20 0.48
CYP2C9 P11712 1/20 0.48
CYP2C19 P33261 1/20 0.48
P2RX7 Q99572 3/20 0.45
HTT P42858 1/20 0.43
MEN1 O00255 1/20 0.43
RAB9A P51151 1/20 0.43
KMT2A Q03164 1/20 0.43
LMNA P02545 1/20 0.41
RORC P51449 1/20 0.41
MAPT P10636 2/20 0.40
PTGES O14684 2/20 0.40
POLB P06746 1/20 0.40
GRM2 Q14416 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1590409 0.93 ALDH1A1 (0.47) ALDH1A1HPGDSMN1; SMN2KDM4ENPSR1
SCHEMBL13047130 0.91 P2RX7 (0.44) ALDH1A1HPGDSMN1; SMN2KDM4ENPSR1
SCHEMBL13047134 0.91 MAPT (0.45) ALDH1A1HPGDSMN1; SMN2KDM4ENPSR1
SCHEMBL13047111 0.89 SMN1; SMN2 (0.45) ALDH1A1HPGDSMN1; SMN2KDM4ENPSR1
SCHEMBL13047047 0.89 ALDH1A1 (0.54) ALDH1A1HPGDSMN1; SMN2KDM4ENPSR1
SCHEMBL1590413 0.85 ALDH1A1 (0.47) ALDH1A1HPGDSMN1; SMN2KDM4ENPSR1
SCHEMBL1590748 0.85 KDM4E (0.54) ALDH1A1HPGDSMN1; SMN2KDM4ENPSR1
SCHEMBL13047121 0.84 HPGD (0.44) ALDH1A1HPGDSMN1; SMN2KDM4ENPSR1
SCHEMBL13046839 0.84 ALDH1A1 (0.46) ALDH1A1HPGDSMN1; SMN2KDM4ENPSR1
SCHEMBL13046666 0.83 TAS1R3 (0.46) ALDH1A1HPGDSMN1; SMN2NPSR1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8546579-B2 Bicycloheteroaryl compounds as P2X7 modulators and uses thereof EVOTEC (US) INC. (US) 2013-10-01 US disclosed
US-8546579-B2 Bicycloheteroaryl compounds as P2X7 modulators and uses thereof EVOTEC (US) INC. (US) 2013-10-01 US disclosed
US-20100292235-A1 Bicycloheteroaryl Compounds as P2x7 Modulators and Uses Thereof SECOND GENOME, INC. 2010-11-18 US disclosed
US-20100292235-A1 Bicycloheteroaryl Compounds as P2x7 Modulators and Uses Thereof SECOND GENOME, INC. 2010-11-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100292235-A1 Bicycloheteroaryl Compounds as P2x7 Modulators and Uses Thereof P2RX7, P2RX3, P2RX2 ALDH1A1 3640/4885HPGD 368/4885SMN1; SMN2 4369/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.